Barclays maintains an 'Overweight' on Brown & Brown (BRO); Organic Growth Turns Positive - Peers Should Also Benefit

Barclays maintains an 'Overweight' on Brown & Brown (NYSE: BRO) price target of $28.00.

Analyst, Sarah DeWitt, said, "BRO reported higher-than-projected 1Q12 EPS, and organic growth turned positive for the first time since 4Q06, which is faster than we anticipated...As BRO's organic growth accelerates, the company could benefit from significant positive operating leverage and EPS growth."

DeWitt sees Arthur J Gallagher (NYSE: AJG), Willis Group (NYSE: WSH), Marsh & McLennan (NYSE: MMC) and Aon Corporation (NYSE: AON) benefitting laterally from Brown & Brown's Q1 report.

For an analyst ratings summary and ratings history on Brown & Brown click here. For more ratings news on Brown & Brown click here.

Shares of Brown & Brown closed at $24.04 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• McGraw Hill (MH) PT Raised to $15 at UBS